News | December 07, 2021
RDIF offers vaccine for adolescents aged 12-17 in India
Sputnik M is a new member of the Sputnik vaccines family
Sputnik M is a new member of the Sputnik vaccines family
The event was organized jointly by Oncology Forum and Fortis Cancer Institute, Delhi NCR
As part of the out-licensing deal with Tabuk, Biocon will develop and manufacture the products, and Tabuk will commercialise them
The facility will supply clinical trial materials for the development of vaccines and biologics up to Phase II stage and is expected to be fully operational by early 2023.
It is an extension of GE Healthcare’s online service delivery enterprise Service Shop
Data builds on promising signal published last week, underscoring the importance of sotrovimab for early treatment of COVID-19
Expanded EUA includes both treatment of patients with Covid-19 and post-exposure prophylaxis (PEP) in high-risk pediatric and infant patients
The Institute of Pulmonology Medical Research & Development organised a symposium on early management of Covid-19
It works with Pfizer to support more rapid innovation and improved clinical manufacturing operations to help develop tomorrow’s therapies
Roche subsidiary TIB Molbiol rapidly developed additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant, as they continue to offer new and accurate detection solutions
Subscribe To Our Newsletter & Stay Updated
